Abstract
There is an increasing need for practical, efficient, and inexpensive ways to explore inherited mutations responsible for genetic diseases, acquired mutations involved in cancer development, and induced mutations in mutational spectrometry. Most of the current methods used for mutation screening are based on PCR, and this has solved the problem of target limitation. Simple and efficient methods such as allele-specific hybridization, allele-specific amplification, ligation, primer extension and artificial introduction of restriction sites, and variants of these methods have been developed for screening large numbers of samples for one particular mutation (for review see Cotton, 1993).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersen, T. L., Holm, R., Nesland, J. M., Heimdal, K. R., Ottestad, L., and Børresen, A.-L. (1993). Prognostic significance of TP53 alterations in breast carcinoma. Br. J. Cancer 68:540–548.
Andersson, B., Ying, J. H., Lewis, D. E., and Gibbs, R. A. (1993). Rapid characterization of HIV-1 sequence diversity using denaturing gradient gel electrophoresis and direct automated DNA sequence of PCR products. PCR Methods Appl. 2(4):293–300.
Børresen, A.-L., Hovig, E., Smith-S—rensen, B., Malkin, D., Lystad, S., Andersen, T. I., Nesland, J. M., Isselbacher, K. J., and Friend, S. H. (1991). Constant dénaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc. Natl. Acad. Sci. USA 88:8405–8409.
Børresen, A.-L., Andersen, T. I., Garber, J., Piraux, N. B., Thorlacius, S., Eyfjrd, J., Ottestad, L., Smith-Sørensen, B., Hovig, E., Malkin, D., and Friend, S. H. (1992). Screening for germ line TP53 mutations in breast cancer patients. Cancer Res. 52:3234–3236.
Condie, A., Eeeles, R., Børresen, A.-L., Coles, C., Cooper, C., and Prosser, J. (1993). Detection of point mutations in the p53 gene. Comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum. Mutat. 2:58–66.
Cornelis, R. S., van Vliet, M., Vos, C. B. J., Cleton-Jansen, A.-M., van de Vrjver, M. J., Peterse, J. L., Meera Khan, P., Børresen, A.-L., Cornelisse, C. J., and Devilee, P (1994). Evidence for a gene on 17p 13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer 54:4200–4206.
Costes, B., Girodon, E., Ghanem, N., Chassignol, M., Thuong, N.T., Dupret, D., and Goossens, M. (1993). Psoralen-modified oligonucleotide primers improve detection of mutations by denaturing gradient gel electrophoresis and provide an alternative to GC-clamping. Hum. Mol. Genet. 2(4):393–397.
Cotton, R. G. H. (1993). Current methods of mutation detection. Mutat. Res. 285:125–144.
Dworniczak, B., Kalydjieva, L., Pankoke, S., Aulehla-Scholz, C., Allen, G., and Horst, J. (1992). Analysis of exon 7 of the human phenylalanine hydroxylase gene: A mutation hot spot? Hum. Mutat. 1(2):138–146.
Fischer, S. G., and Lerman, L. S. (1983). DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory. Proc. Natl. Acad. Sci. USA 80:1579–1583.
Gotoh, O., and Tagashira, Y. (1981). Location of frequently opening regions of natural DNA’s and their relation to functional loci. Biopolymers 20(5):1043–1058.
Guldberg, P., Henriksen, K. F., and Guttler, F. (1993). Molecular analysis of phenylketonuria in Denmark:99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 17(1):141–146.
Heimdal, K. R., Lothe, R. A., Lystad, S., Holm, R., Foss, S. D., and Børresen, A.-L. (1993). No germline TP53 mutations detected in familial and bilateral testicular cancer. Genes Chromosomes Cancer 6(2):92–97.
Hovig, E., Smith-Sørensen, B., Brøgger, A., and Børresen, A.-L. (1991). Constant dénaturant gel electrophoresis, a modification of denaturing gel electrophoresis, in mutation detection. Mutat. Res. 262:63–71.
Hovig, E., Smith-Sørensen, B., Gebhardt, M. C., Ryberg, D., Lothe, R., and Børresen, A.-L. (1992). Alterations in retinoblastoma susceptibility gene exon 21 are not common in human tumours. Genes Chromosomes Cancer 5 (2):97–103.
Hovig, E., Smith-Sørensen, B., and Børresen, A.-L. (1994). Detection of mutation by denaturing gradient gel electrophoresis, in:Current Protocols in Human Genetics (N. Dracopoli, D. Moir, D. Smith, J. Haines, C. Morton, B. Korf, C. Seideman, and J. Seidman, eds.) Current Protocols, New York, Chapter 7.5.
Husgafvel-Pursiainen, K., Ridanpää, M., Hackman, P., Antilla, S., Karjalainen, A., Önfelt, A., Børresen, A.-L., and Vainio, H. (1992). Detection of ras gene mutations in human lung cancer: Comparison of two screening assays based on the polymerase chain reaction. Environ. Health Perspect. 98:183–185.
Khrapko, K., Hanekamp, J. S., Thilly, W. G., Belenki, A., Foret, F., and Karger, B. L. (1994). Constant denaturant capillary electrophoresis (CDCE):A high resolution approach to mutational analysis. Nucleic Acids Res. 22:364–372.
Lerman, L. S., and Silverstein, K. (1987). Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol. 155:482–501.
Mclntyre, J. R., Smith-Sørensen, B., Friend, S. H., Kassell, J., Børresen, A.-L., Yu Xin Yan, Russo, C., Sato, J., Barbier, N., Miser, J., Malkin, D., and Gebhardt, M. C. (1994). Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J. Clin. Oncol. 12:925–930.
Malkin, D., Jolly, K. W., Barbier-Piraux, N., Look, T., Friend, S. H., Gebbhardt, M. C., Andersen, T. I., Børresen, A.-L., Li, F. P., Garber, J., and Strong, L. C. (1992). Germline mutations in the p53 tumor suppressor gene in children and young adults with second malignant neoplasms. N. Eng. J. Med. 20:1309–1315.
Peng, H. Q., Malkin, D., Bailey, D., Gallie, B. L., Bulbul, M., Jewet, M., Buchanan, J., and Goss, P. E. (1993). Mutations of the p53 genes do not occur in testis cancer. Cancer Res. 53:3574–3578.
Poland, D. (1974). Recursion relation generation of probability profiles for specific-sequence macromolecules with long-range correlations. Biopolymers 13:1859–1871.
Ridanpää, M., and Husgafvel-Pursiainen, K. (1993). Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: Detection of K-ras point mutations in human lung tumour DNA. Hum. Mol. Genet. 2(6):639–644.
Ryberg, D., Kure, E., Lystad, S., Skaug, V., Stangeland, L., Mercy, L, Børresen, A.-L., and Haugen, A. (1994). Mutations in lung tumors. Relationship to putative susceptibility markers for cancer. Cancer Res. 54:1551–1555.
Seruca, R., David, L., Holm, R., Nesland, J. M., Fangan, B. M., Castedo, S., Sobrinho-Simoes, M., and Børresen, A.-L. (1992). P53 mutations in gastric carcinomas. Br. J. Cancer 65(5):708–710.
Sheffield, V. C., Cox, D. R., Lerman, L. S., and Myers, R. M. (1989). Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc. Nad. Acad. Sci. USA 86:232–236.
Smith-Sørensen, B., Hovig, E., Andersson, B., and Børresen, A.-L. (1992). Screening for base mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant dénaturant gel electrophoresis (CDGE). Mutat. Res. 269:41–53.
Smith-Sørensen, B., Gebhardt, M. C., Kloen, P., Aguilar, F., Friend, S. H., and Børresen, A.-L. (1993). Screening for TP53 mutations in osteosarcomas using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE). Hum. Mutat. 2:274–285.
Thorlacius, S., Børresen, A.-L., and Eyfjörd, J. (1993). Somatic p53 mutations in human breast carcinomas in an Icelandic population, a prognostic factor. Cancer Res. 53:1637–1641.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Børresen, AL. (1996). Constant Denaturant Gel Electrophoresis (CDGE) in Mutation Screening. In: Pfeifer, G.P. (eds) Technologies for Detection of DNA Damage and Mutations. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0301-3_20
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0301-3_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0303-7
Online ISBN: 978-1-4899-0301-3
eBook Packages: Springer Book Archive